Similar articles

• Clinical experience with a new secretolytic drug.

  Villa R, Orlandini GC. Villa R, et al. Minerva Med. 1969 Sep 22;60(76):3607-10. Minerva Med. 1969. PMID: 5823759 English. No abstract available.
• The mucolytic agent bromhexine (bisolvon) in chronic lung disease. A double-blind crossover trial.

  Cobbin DM, Elliott FM, Rebuck AS. Cobbin DM, et al. Aust N Z J Med. 1971 May;1(2):137-40. doi: 10.1111/j.1445-5994.1971.tb02280.x. Aust N Z J Med. 1971. PMID: 4935896 Clinical Trial. No abstract available.
• A clinical trial of bromhexine.

  Thompson KJ, Reeve J. Thompson KJ, et al. N Z Med J. 1972 Aug;76(483):73-6. N Z Med J. 1972. PMID: 4264310 Clinical Trial. No abstract available.
• [Usefulness of mucoactive drugs in respiratory diseases].

  Serrano J, Sanchis J. Serrano J, et al. Arch Bronconeumol. 1998 Jan;34(1):28-35. doi: 10.1016/s0300-2896(15)30502-0. Arch Bronconeumol. 1998. PMID: 9522017 Review. Spanish. No abstract available.
• Aerosolized detergents and mucolytic agents in the treatment of stable chronic obstructive pulmonary disease.

  Barton AD. Barton AD. Am Rev Respir Dis. 1974 Dec;110(6 Pt 2):104-10. doi: 10.1164/arrd.1974.110.6P2.104. Am Rev Respir Dis. 1974. PMID: 4613216 Review. No abstract available.